Inactive

This is a request for information (RFI) only for the capability of innovative commercial services that support the distribution of USG owned, orally administered, direct-acting antiviral therapeutics ... This is a request for information (RFI) only for the capability of innovative commercial services that support the distribution of USG owned, orally administered, direct-acting antiviral therapeutics that are under an Emergency Use Authorization (EUA) granted by the Food and Drug Administration (FDA) to treat outpatients.